These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30641865)

  • 1. Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity.
    Springer M; Moco S
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30641865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity of dietary polyphenols: The role of metabolites.
    Luca SV; Macovei I; Bujor A; Miron A; Skalicka-Woźniak K; Aprotosoaie AC; Trifan A
    Crit Rev Food Sci Nutr; 2020; 60(4):626-659. PubMed ID: 30614249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Mediterranean Dietary Polyphenol Intake and Obesity.
    Castro-Barquero S; Lamuela-Raventós RM; Doménech M; Estruch R
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30336572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review.
    Barber TM; Kabisch S; Randeva HS; Pfeiffer AFH; Weickert MO
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889827
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary polyphenols and obesity.
    Meydani M; Hasan ST
    Nutrients; 2010 Jul; 2(7):737-51. PubMed ID: 22254051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
    Carpene C; Gomez-Zorita S; Deleruyelle S; Carpene MA
    Curr Med Chem; 2015; 22(1):150-64. PubMed ID: 25139462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adipocentric perspective of resveratrol as a calorie restriction mimetic.
    Barger JL
    Ann N Y Acad Sci; 2013 Jul; 1290():122-9. PubMed ID: 23855474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, Metabolic Syndrome, and Gut Microbiota.
    Chaplin A; Carpéné C; Mercader J
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400297
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang C; Liu J; He X; Sheng Y; Yang C; Li H; Xu J; Xu W; Huang K
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene.
    Pan MH; Wu JC; Ho CT; Lai CS
    Biofactors; 2018 Jan; 44(1):50-60. PubMed ID: 29315906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
    Poulsen MM; Vestergaard PF; Clasen BF; Radko Y; Christensen LP; Stødkilde-Jørgensen H; Møller N; Jessen N; Pedersen SB; Jørgensen JO
    Diabetes; 2013 Apr; 62(4):1186-95. PubMed ID: 23193181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sulfotransferases in resveratrol metabolism in human adipocytes.
    Gheldof N; Moco S; Chabert C; Teav T; Barron D; Hager J
    Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28523759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol-Induced Effects on Body Fat Differ Depending on Feeding Conditions.
    Milton-Laskibar I; Gómez-Zorita S; Aguirre L; Fernández-Quintela A; González M; Portillo MP
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss.
    Rupasinghe HP; Sekhon-Loodu S; Mantso T; Panayiotidis MI
    Pharmacol Ther; 2016 Sep; 165():153-63. PubMed ID: 27288729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct ingestion method for enhancing production and bioavailability of resveratrol and other phytoalexins in Vitis vinifera.
    Leifer A; Barberio DM
    Med Hypotheses; 2016 Mar; 88():1-5. PubMed ID: 26880624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota.
    Wang P; Gao J; Ke W; Wang J; Li D; Liu R; Jia Y; Wang X; Chen X; Chen F; Hu X
    Free Radic Biol Med; 2020 Aug; 156():83-98. PubMed ID: 32305646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols.
    Anhê FF; Choi BSY; Dyck JRB; Schertzer JD; Marette A
    Trends Endocrinol Metab; 2019 Jun; 30(6):384-395. PubMed ID: 31076221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.
    Zhao L; Zhang Q; Ma W; Tian F; Shen H; Zhou M
    Food Funct; 2017 Dec; 8(12):4644-4656. PubMed ID: 29152632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese [III] Tetrakis [5,10,15,20]-Benzoic Acid Porphyrin Reduces Adiposity and Improves Insulin Action in Mice with Pre-Existing Obesity.
    Brestoff JR; Brodsky T; Sosinsky AZ; McLoughlin R; Stansky E; Fussell L; Sheppard A; DiSanto-Rose M; Kershaw EE; Reynolds TH
    PLoS One; 2015; 10(9):e0137388. PubMed ID: 26397111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.